Skip to main content
. 2019 Nov 15;7:320. doi: 10.3389/fbioe.2019.00320

Figure 5.

Figure 5

(A) Design of TPETCAQ. (B) Synthesis of TPETCAQ-1 NPs and TPETCAQ NPs. (C) Time-dependent bioluminescent 4T1-luc tumor imaging of mice after intratumoral administration of TPETCAQ NPs (30 μL, 1 mg mL−1 for TPETCAQ, top panel) or saline (bottom panel) with light irradiation (300 mW cm−2, 5 min) at 1 h post-injection. (D) Tumor volume measurement for different groups of mice. ***P < 0.001.